The Board of Directors of Fine Foods & Pharmaceuticals N T M S p A approved the Group s Interim Financial Report as of 31 March 2024: EBITDA Margin reached 13 5%, exceeding historical levels marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Fine Foods & Pharmaceuticals N T M S p A : Updates on nominations for renewal of the Board of Statutory Auditors marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.